Friday, July 10, 2026

Drug profile · INN

entolimod

entolimod (ENTOLIMOD TMC) is a toll-like receptor 5 agonist.

EMA: application withdrawn Antineoplastic and immunomodulating agents (L03) L03A
Patents linked 0
Pipeline programs 0
News articles 0
Drug details — entolimod
Class
Antineoplastic and immunomodulating agents (L03)
Route
Patents
0
Programs
0
Data quality
0.83

Quick answer

entolimod (ENTOLIMOD TMC) is a toll-like receptor 5 agonist.

Key facts

INN entolimod
Brand ENTOLIMOD TMC
Mechanism Toll-like receptor 5 agonist
Target Toll-like receptor 5
Therapeutic class Antineoplastic and immunomodulating agents (L03)
ATC code L03A

Mechanism of action

Toll-like receptor 5 agonist

Primary target: Toll-like receptor 5

Approval history

Authority Status Date
EMA application withdrawn

Related & competitor drugs

  1. abiraterone acetate Antineoplastic and immunomodulating agents (L02)
  2. anagrelide Antineoplastic and immunomodulating agents (L01)
  3. apremilast Antineoplastic and immunomodulating agents (L04)
  4. arsenic trioxide Antineoplastic and immunomodulating agents (L01)
  5. axitinib Antineoplastic and immunomodulating agents (L01)
  6. azacitidine Antineoplastic and immunomodulating agents (L01)

Frequently asked questions

What is entolimod?

entolimod (ENTOLIMOD TMC) is a toll-like receptor 5 agonist.

What is the brand name for entolimod?

ENTOLIMOD TMC is a marketed brand name for entolimod. Check FDA Drugs@FDA for the current US label holder and prescribing information.